Immunoglobulin against Toxoplasma gondii of the person

General characteristics. Structure:

Active ingredients - antibodies, active in relation to Toxoplasma gondii. 1 ml of drug contains not less than 600 ME of antibodies to Toxoplasma gondii;

excipients - glycine (glycine, the aminoacetic acid), sodium chloride.

Main properties: drug is protein fraction of serum or a blood plasma of the immunizirovanny donors checked for lack of antibodies to VICh-1, VICh-2, to a virus of hepatitis C and a surface antigen of a virus of hepatitis B, cleared and concentrated by a fractionation method spirtovodny by the besieging solutions, the virus inactivation which passed a stage solvent-detergentnym by method, with the high content of antibodies to Toxoplasma gondii. Protein content in 1.0 ml of drug from 0:09 g to 0:11 g. Transparent or slightly opalescent, colourless or yellowish liquid. In the course of storage emergence of the insignificant deposit disappearing when stirring is allowed. Drug does not contain preservative and antibiotics.

Pharmacological properties:

Drug contains in high concentration of an antibody specific to Toxoplasma gondii: in one dose (1.5 ml) - not less than 900 ME. Compensates for the deficiency of antibodies of the specified specificity which is available in an organism.

Indications to use:

Apply to treatment of pregnant women of patients with a toxoplasmosis and related obstetric pathology, and also patients with defeat against the background of a toxoplasmosis of urogenital ways.

Route of administration and doses:

The first course of treatment of pregnant women with symptoms of a toksoplazmenny infection or chronic toxoplasmosis and the related obstetric pathology is carried out after 12 - 15 weeks of pregnancy. Immunoglobulin is entered intramusculary on 1.5 ml of 1 times in 3 days a course 7 - 10 injections. Second is treated after 30 weeks of pregnancy according to the same scheme.

According to the same scheme the first course of treatment of patients with symptoms of defeat of urogenital ways against the background of a toxoplasmosis is conducted. The second year of treatment to patients is conducted in 4 weeks after the first. Drug is used under observation of the doctor.

Features of use:

It is forbidden to administer the drug intravenously!

And in the next 3 days antihistaminic drugs are recommended to the patients having allergic diseases or having them in the anamnesis in day of administration of immunoglobulin. To the persons suffering from immune general diseases (diseases of blood, connecting fabric, nephrite, etc.), it is necessary to enter immunoglobulin against the background of the corresponding therapy.

Side effects:

Reactions to administration of immunoglobulin, as a rule, are absent. In rare instances there can be local reactions in the form of a hyperemia and temperature increase to 37.5 ^{° C} within the first days. With the changed reactivity drug can cause reactions of an allergy of different type in certain people, and in exclusively exceptional cases - an acute anaphylaxis. In this regard the persons who received drug have to be under medical observation within 30 minutes.

Interaction with other medicines:

The combination with other specific medicines is possible.

Contraindications:

Administration of immunoglobulin is contraindicated to the persons having heavy allergic reactions to introduction of proteinaceous blood preparations of the person in the anamnesis.

Overdose:

It was not studied.

Storage conditions:

In the dry, protected from light place at a temperature from 2 °C to 8 °C. To store in the place, unavailable to children.

Issue conditions:

According to the recipe

Packaging:

On 1.5 ml (1 dose) in an ampoule. On 5 ampoules in a pack.